Substance P and secretoneurin in vitreous aspirates of patients with various vitreoretinal diseases.
By means of highly sensitive radioimmunoassays, the levels of substance P (SP) and secretoneurin (SN) were detected in vitreous aspirates of patients with macular holes which served as controls, in patients with nonproliferative diabetic retinopathy (DR), active proliferative diabetic retinopathy (active PDR), inactive PDR, rhegmatogenous retinal detachment and proliferative vitreoretinopathy (PVR). Furthermore, SN-like immunoreactivities were characterized by reversed phase-HPLC. The concentration of SN was more than 20-fold higher in macular holes when compared with SP and reversed phase HPLC revealed evidence that the vitreous levels of SN represent authentic SN. SN was significantly decreased in patients with nonproliferative DR, active PDR and inactive PDR by more than 70% which seems to result from a reduced expression and/or secretion from the cilary epithelium and a reduced release from the retina both due to diabetes mellitus. By contrast SP was increased in rhegmatogenous retinal detachment most obviously due to an enhanced outflow of the peptide through retinal breaks. Despite their proangiogenic activities, SP and SN are unlikely to be involved in the pathogenesis of neovascularizations in DR because of their unchanged and reduced levels, respectively, but the low levels of both peptides may facilitate the regression of vasoproliferations following laser photocoagulation.
Lorenz
Katrin
K
Department of Ophthalmology, Medical University of Innsbruck, Anichstrasse 35, A-6020 Innsbruck, Austria.
Troger
Josef
J
Fischer-Colbrie
Reiner
R
Kremser
Bernhard
B
Schmid
Eduard
E
Kralinger
Martina
M
Teuchner
Barbara
B
Bechrakis
Nikolaos
N
Kieselbach
Gerhard
G
D000368:Aged; D003930:Diabetic Retinopathy / Q000378:metabolism*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009479:Neuropeptides / Q000032:analysis*; D012163:Retinal Detachment / Q000378:metabolism*; D012167:Retinal Perforations / Q000378:metabolism*; D053381:Secretogranin II / Q000032:analysis*; D013373:Substance P / Q000032:analysis*; D018630:Vitreoretinopathy, Proliferative / Q000378:metabolism*; D014822:Vitreous Body / Q000378:metabolism*
D009479:Neuropeptides; D053381:Secretogranin II; C081159:secretoneurin; D013373:Substance P